ExomeFocus®

Cost-efficient and targetd – focused on high-impact variants

ExomeFocus® is designed for patients where a targeted analysis is the right first step. Our proprietary software systematically identifies high-impact variants across the patient’s exome — drawing on our extensive internal database of genetic variants and publicly available databases. These high-impact variants are then evaluated by our scientific team for clinical relevance to the patient’s phenotype. A cost-efficient alternative — with the option to upgrade to Trio ExomeXtra® at any time.

Is your patient insured in Germany? Our colleagues at the Zentrum für Humangenetik Tübingen will gladly support you!

The Benefits of Our ExomeXtra® at a Glance

Better than exome

Detect 20% more disease-causing variants compared to standard WES

Smarter than genome

Deeper coverage where it counts — detecting variant classes that standard WGS does not reliably capture

CNV detection at array-CGH resolution

Genome-wide detection of deletions and duplications

Reports with direct clinical impact

Variants interpreted in context, with actionable recommendations — created by our interdisciplinary team

Our Promise to You

Graues Icon das die Dauer symbolisiert

Fast Turnaround Time

Typically 3–4 weeks after sample receipt

Icon zur Visualisierung unseres Sicherheitsversprechens

Safety

Highest confidentiality and quality standards

Icon das Zuverlässigkeit symbolisiert

Reliability

Reliable support throughout all steps

Einfache grafische Darstellung eines Befund

Comprehensibility

Clearly prepared medical report

Service Details

Scope of Analysis

  • Coding and non-coding disease-associated regions — analyzed through our curated High-Impact Variant List
  • Mosaic variant detection
  • Genome-wide CNV detection
  • Screening for relevant infections

Medical Report Includes

  • All relevant variant types: sequence variants (SNV, indel), small copy-number variants (CNV), and large aneuploidies – including mosaic variants
  • Variants of ACMG classes 3, 4, and 5 — classified and interpreted in the context of your patient’s phenotype
  • Variants of uncertain significance (VUS) further classified by likelihood of pathogenic effect
  • Direct recommendations for clinical management and further testing, where applicable
  • Assessment of genetic relevance for family planning

Optional Add-On Services

  • Analysis of all ACMG genes
  • HLA typing
  • Pharmacogenetic analysis including dosing information
  • Upgrade to Trio ExomeXtra® available at any time

Sample Report

Our Standard Sample Requirements

  • 1 ml–2 ml EDTA blood (recommended sample type)
  • Genomic DNA (1 µg–2 µg)
  • DBS cards, buccal swabs, or saliva are also possible

Here you can find more information on how to ship your sample safely.

Other sample material sources are possible on request. Please note: In case of insufficient sample quality, the analysis might fail. If you have more than one option of samples, please contact us (diagnostic-support@cegat.com) and we will assist you in selecting the optimal sample for your patient.

Diagnostic Process

Icon Prozessablauf

Counseling & Test Selection

Icon Prozessablauf
Icon Prozessablauf

Sampling & Shipment

Icon Prozessablauf
Icon Prozessablauf

Sample Analysis

Icon Prozessablauf
Icon Prozessablauf

Medical Report & Counseling

Further Information

5 years of ExomeXtra® with Dr. Florian Battke

The Evolution of ExomeXtra®

Webinar: Learn How We Can Help You Solve Complex Patient Cases

Downloads

Order Form ExomeXtra®
Sample Report ExomeFocus®
Rare Disease Diagnostics Brochure
Rare Disease Diagnostics Flyer (EN)
Exome Diagnostics Tech Note (EN)
What Is the Real Diagnostic Benefi t of Whole-Genome Sequencing?

Contact Us

Do you have a question, or are you interested in our service?

The fields marked with (*) are mandatory and must be completed.

Diagnostic Support

We will assist you in selecting the diagnostic strategy – for each patient.

Germline Team CeGaT